Portal de Periódicos da CAPES

A risankizumab super responder profile identified by long‐term real‐life observation‐ IL PSO ( ITALIAN LANDSCAPE PSORIASIS )

2023; Wiley; Volume: 38; Issue: 1 Linguagem: Inglês

10.1111/jdv.19464

1468-3083

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Giuseppe Argenziano, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo Giovanni Carrera, Giovanni Damiani, Paolo Dapavo, Valentina Dini, Gabriella Fabbrocini, Chiara Franchi, Francesca Maria Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo Valerio Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Francesca Sampogna, Massimo Travaglini, Mario Valenti, Antonio Costanzo, Alessandra Narcisi,

Psoriasis: Treatment and Pathogenesis

The data that support the findings of this study are available from the corresponding author upon reasonable request.